2-(3-Ethoxy-4-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 500mg

(7s)-7-Methyl-1,3,4,6,7,8,9,9a-octahydropyrazino[2,1-c][1,4]oxazine, 98%, 100mg

Fmoc-(S)-3-Amino-3-(2,4-dichlorophenyl)-propionic acid, 97%, 1g

Phenylphosphonic acid, 95.0%, 500g

2-Bromo-6-iodo-3-methoxypyridine, 95.0%, 250mg

2-(2-Fluorophenoxy)-1-ethanamine, 97.0%, 1g

6-Bromo-2,2-dimethyl-2H-chromene, 97.0%, 250mg

Strychnine hydrochloride, for biochemistry, 10 g, plastic packaging.

(S)-(-)-5,5'-Dichloro-6,6'-dimethoxy-2,2'-bis(diphenylphosphino)-1,1'-biphenyl, 97%, 100mg

GC capillary column ROTI®Cap-624, 30 m, 0.25 mm, 1.40 µm, 1 Piece(s)

Methyl (S)-3-(4-bromothiazol-2-yl)-2-((tert-butoxycarbonyl)amino)propanoate, 97%, 1g

2-Methylquinoline-8-carbonitrile, 97%, 2g

N-(1,3,4-Thiadiazol-2-yl)nicotinamide hydrochloride, 97%, 1g